White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
Graf Acquisition Corp. IV’s Business Combination with NkGen Biotech
Cooley LLP acted as legal advisor to NKGen and NKMax, while White & Case LLP acted as legal advisor to Graf on the transaction. Graf Acquisition...
White & Case Promotes 26 to Local Partner and 14 to Counsel
Global law firm White & Case LLP has promoted 26 lawyers to local partner and 14 lawyers to counsel. “Our local partner and counsel promotions span...
Viatris’ Acquisition of Famy Life Sciences
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
Apollomics’ $899 Million Business Combination with Maxpro Capital Acquisition Corp.
White & Case advised Apollomics Inc., while Nelson Mullins Riley & Scarborough and Harneys represented Maxpro on the deal. Apollomics Inc., a late-stage clinical biopharmaceutical company,...
LOTTE’s $160 Million Acquisition of Pharmaceutical Manufacturing Facility from Bristol Myers Squibb
Baker McKenzie advised BMS, while White & Case advised LOTTE Corporation on the deal. Bristol Myers Squibb (BMS) executed the sale of its manufacturing facility in...
Advanz Pharma’s Acquisition of Intercept Pharmaceuticals
White & Case and Vischer advised Advanz Pharma on the deal. Advanz Pharma announced its acquisition of the ex-US business of Intercept Pharmaceuticals. ADVANZ PHARMA is a...
Zimmer Biomet’s Spinoff of ZimVie
White & Case has advised Zimmer Biomet Holdings, Inc., a global medical technology leader, and ZimVie Inc. (Nasdaq: ZIMV) on Zimmer Biomet’s spinoff of ZimVie. Demarest...
Ginkgo Bioworks’ $15 Billion Merger with Soaring Eagle Acquisition Corp.
Latham & Watkins LLP and Wachtell, Lipton, Rosen & Katz represented Ginkgo Bioworks, while White & Case LLP advised Soaring Eagle Acquisition Corp. in the transaction....
Entrada Therapeutics’ $116 Million Series B Financing
White & Case LLP advised Qatar Investment Authority on the deal. Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, participated in a US$116...